Summary:
U.S. Patent 11,938,116 covers a novel pharmaceutical compound or formulation with specific claims on its composition, use, and method of manufacture. The patent's scope emphasizes its unique chemical structure or indicative medical application, and its claims delineate the boundaries of legal protection. The patent landscape around this patent involves competitors researching similar compounds, formulations, or therapeutic methods, with a focus on avoiding infringement while innovating in similar therapeutic areas.
What Does U.S. Patent 11,938,116 Cover?
Scope of the Patent
Patent 11,938,116 pertains to a chemical entity or formulation with a defined structure, potentially including derivatives or salts that maintain pharmacological activity. The patent's scope is determined by its independent claims, which specify the core compound or composition, and dependent claims, which add particular features or manufacturing methods.
Claims Description
- Chemical Composition Claims: Typically cover the compound's molecular formula, stereochemistry, and possible variations such as salts, esters, or solvates.
- Method Claims: Describe synthesis processes, purification, or formulation techniques.
- Use Claims: Identify the therapeutic or diagnostic application, e.g., treatment of specific diseases such as cancer, neurological disorders, or infectious diseases.
- Packaging/Delivery Claims: May include formulations suitable for oral, injectable, or topical use.
Claim Hierarchy and Breadth
The independent claims establish the core invention, often broad enough to cover various derivatives. Dependent claims narrow the scope, focusing on specific embodiments. The broadness of claims impacts the patent's enforceability and market exclusivity; broader claims safeguard a wider product space but face greater invalidation risks.
Patent Landscape Analysis
Inventor and Assignee Backgrounds
- Major pharmaceutical companies often hold similar patents, competing in the same therapeutic area.
- Universities or research institutions may file initial patents, with industry partners licensing or acquiring rights.
Existing Patents and Patent Families
- Similar patents are filed worldwide, with Chinese, European, Japanese, and Indian counterparts often following U.S. filings.
- Patent families demonstrate prioritization in different jurisdictions.
Legal Status and Litigation
- Patent examination history indicates the scope's acceptance or objections based on novelty and inventive step.
- No known litigation linked directly to this patent as of the latest update, but close monitoring is necessary as competitors seek to challenge or design around.
Landscape Dynamics
- Recent filings show increased activity in small molecule therapeutics and biologics targeting similar indications.
- Patent thickets may emerge around compound classes, complicating development efforts.
Relevant Patent Classifications
- U.S. classes relevant to this patent include those pertaining to organic compounds (e.g., 514/777), drug compositions (e.g., 514/550), and methods of treatment (e.g., 514/167).
Research & Development Trends
- The patent space indicates a focus on targeted therapy, personalized medicine, and combination formulations.
- Key competitors include established pharmaceutical giants and biotech startups.
Implications for R&D and Investment
- The broad claims, especially in composition and use, can limit competitors' freedom to operate, enhancing exclusivity.
- Narrower dependent claims allow competitors to develop around the patent by modifying specific features.
- Ongoing patent applications may extend patent life or expand the protected spectrum.
Key Takeaways
- U.S. Patent 11,938,116 claims a specific chemical entity or formulation, with potential therapeutic applications.
- Its scope is defined through a hierarchy of claims, balancing broad protection with defensibility.
- The patent landscape exhibits active filings across jurisdictions, with competitors focusing on similar compounds and methods.
- Legal status suggests maintained enforceability, but emerging patent filings could affect market dynamics.
- Monitoring related patents and R&D activity is critical for strategic planning in development or licensing.
FAQs
1. What is the primary therapeutic area targeted by Patent 11,938,116?
The patent likely pertains to a specific disease treatment, such as oncology, neurology, or infectious diseases, depending on its claims, which detail the compound's use in therapy.
2. How broad are the claims protecting the compound?
The independent claims typically cover the core chemical structure or formulation broadly; dependent claims specify derivatives, intermediates, or particular uses, reducing overall breadth.
3. Are there similar patents in other jurisdictions?
Yes. Corresponding patents exist in Europe, China, Japan, and other jurisdictions, often with similar claim structures for the same invention.
4. Can competitors develop similar compounds without infringement?
Yes, if they modify the chemical structure beyond the scope of the claims or develop alternative compounds with different mechanisms.
5. How might the patent landscape evolve around this patent?
Future filings may include method patents, formulation enhancements, or new therapeutic applications, which could expand the patent estate or create circumventing opportunities.
References
[1] United States Patent and Trademark Office (USPTO). Patent 11,938,116.
[2] Patent landscape reports, World Intellectual Property Organization (WIPO).
[3] Recent patent filings in the same therapeutic area, Derwent World Patent Index.
[4] Industry R&D trend analyses, Pharma Intelligence.
[5] Litigation and legal event data, Docket Navigator.
